516 related articles for article (PubMed ID: 33934221)
1. A new non-aggregative splicing isoform of human Tau is decreased in Alzheimer's disease.
García-Escudero V; Ruiz-Gabarre D; Gargini R; Pérez M; García E; Cuadros R; Hernández IH; Cabrera JR; García-Escudero R; Lucas JJ; Hernández F; Ávila J
Acta Neuropathol; 2021 Jul; 142(1):159-177. PubMed ID: 33934221
[TBL] [Abstract][Full Text] [Related]
2. Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau).
Gibbons GS; Kim SJ; Robinson JL; Changolkar L; Irwin DJ; Shaw LM; Lee VM; Trojanowski JQ
Acta Neuropathol Commun; 2019 Mar; 7(1):34. PubMed ID: 30832741
[TBL] [Abstract][Full Text] [Related]
3. Intron retention as a productive mechanism in human MAPT: RNA species generated by retention of intron 3.
Ruiz-Gabarre D; Vallés-Saiz L; Carnero-Espejo A; Ferrer I; Hernández F; Garcia-Escudero R; Ávila J; García-Escudero V
EBioMedicine; 2024 Feb; 100():104953. PubMed ID: 38181704
[TBL] [Abstract][Full Text] [Related]
4. Transactive response DNA-binding protein 43 (TDP-43) regulates alternative splicing of tau exon 10: Implications for the pathogenesis of tauopathies.
Gu J; Chen F; Iqbal K; Gong CX; Wang X; Liu F
J Biol Chem; 2017 Jun; 292(25):10600-10612. PubMed ID: 28487370
[TBL] [Abstract][Full Text] [Related]
5. Glycogen synthase kinase-3 plays a crucial role in tau exon 10 splicing and intranuclear distribution of SC35. Implications for Alzheimer's disease.
Hernández F; Pérez M; Lucas JJ; Mata AM; Bhat R; Avila J
J Biol Chem; 2004 Jan; 279(5):3801-6. PubMed ID: 14602710
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of tau isoform transcripts in sporadic tauopathies.
Connell JW; Rodriguez-Martin T; Gibb GM; Kahn NM; Grierson AJ; Hanger DP; Revesz T; Lantos PL; Anderton BH; Gallo JM
Brain Res Mol Brain Res; 2005 Jun; 137(1-2):104-9. PubMed ID: 15950767
[TBL] [Abstract][Full Text] [Related]
7. Tau alternative splicing in familial and sporadic tauopathies.
Niblock M; Gallo JM
Biochem Soc Trans; 2012 Aug; 40(4):677-80. PubMed ID: 22817715
[TBL] [Abstract][Full Text] [Related]
8. The Role of Tau Proteoforms in Health and Disease.
Waheed Z; Choudhary J; Jatala FH; Fatimah ; Noor A; Zerr I; Zafar S
Mol Neurobiol; 2023 Sep; 60(9):5155-5166. PubMed ID: 37266762
[TBL] [Abstract][Full Text] [Related]
9. mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies.
Caccamo A; Magrì A; Medina DX; Wisely EV; López-Aranda MF; Silva AJ; Oddo S
Aging Cell; 2013 Jun; 12(3):370-80. PubMed ID: 23425014
[TBL] [Abstract][Full Text] [Related]
10. An SRp75/hnRNPG complex interacting with hnRNPE2 regulates the 5' splice site of tau exon 10, whose misregulation causes frontotemporal dementia.
Wang Y; Wang J; Gao L; Stamm S; Andreadis A
Gene; 2011 Oct; 485(2):130-8. PubMed ID: 21723381
[TBL] [Abstract][Full Text] [Related]
11. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
Stancu IC; Ferraiolo M; Terwel D; Dewachter I
Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
[TBL] [Abstract][Full Text] [Related]
12. The role of tau phosphorylation and cleavage in neuronal cell death.
Chun W; Johnson GV
Front Biosci; 2007 Jan; 12():733-56. PubMed ID: 17127334
[TBL] [Abstract][Full Text] [Related]
13. Tau Isoforms: Gaining Insight into
Corsi A; Bombieri C; Valenti MT; Romanelli MG
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499709
[TBL] [Abstract][Full Text] [Related]
14. Tau protein as a differential biomarker of tauopathies.
Sergeant N; Delacourte A; Buée L
Biochim Biophys Acta; 2005 Jan; 1739(2-3):179-97. PubMed ID: 15615637
[TBL] [Abstract][Full Text] [Related]
15. A new TAO kinase inhibitor reduces tau phosphorylation at sites associated with neurodegeneration in human tauopathies.
Giacomini C; Koo CY; Yankova N; Tavares IA; Wray S; Noble W; Hanger DP; Morris JDH
Acta Neuropathol Commun; 2018 May; 6(1):37. PubMed ID: 29730992
[TBL] [Abstract][Full Text] [Related]
16. Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.
Šimić G; Babić Leko M; Wray S; Harrington C; Delalle I; Jovanov-Milošević N; Bažadona D; Buée L; de Silva R; Di Giovanni G; Wischik C; Hof PR
Biomolecules; 2016 Jan; 6(1):6. PubMed ID: 26751493
[TBL] [Abstract][Full Text] [Related]
17. Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies.
Irwin DJ; Cohen TJ; Grossman M; Arnold SE; Xie SX; Lee VM; Trojanowski JQ
Brain; 2012 Mar; 135(Pt 3):807-18. PubMed ID: 22366796
[TBL] [Abstract][Full Text] [Related]
18. Posttranslational modifications of tau--role in human tauopathies and modeling in transgenic animals.
Chen F; David D; Ferrari A; Götz J
Curr Drug Targets; 2004 Aug; 5(6):503-15. PubMed ID: 15270197
[TBL] [Abstract][Full Text] [Related]
19. Tauopathies.
Hernández F; Avila J
Cell Mol Life Sci; 2007 Sep; 64(17):2219-33. PubMed ID: 17604998
[TBL] [Abstract][Full Text] [Related]
20. Regulation of alternative splicing of tau exon 10.
Qian W; Liu F
Neurosci Bull; 2014 Apr; 30(2):367-77. PubMed ID: 24627328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]